Geode Capital Management LLC Sells 94,442 Shares of HCA Healthcare, Inc. $HCA

Geode Capital Management LLC decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,797,902 shares of the company’s stock after selling 94,442 shares during the quarter. Geode Capital Management LLC owned about 1.62% of HCA Healthcare worth $1,447,546,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Park Place Capital Corp lifted its holdings in shares of HCA Healthcare by 2,336.0% in the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after acquiring an additional 1,168 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after buying an additional 2,698 shares during the last quarter. Harrell Investment Partners LLC lifted its stake in shares of HCA Healthcare by 176.3% during the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after acquiring an additional 1,158 shares during the last quarter. Simon Quick Advisors LLC increased its stake in HCA Healthcare by 616.9% in the second quarter. Simon Quick Advisors LLC now owns 7,147 shares of the company’s stock worth $2,738,000 after purchasing an additional 6,150 shares during the period. Finally, Simplicity Wealth LLC boosted its stake in shares of HCA Healthcare by 92.7% during the second quarter. Simplicity Wealth LLC now owns 1,798 shares of the company’s stock valued at $689,000 after purchasing an additional 865 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on HCA shares. KeyCorp upped their target price on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. Sanford C. Bernstein restated a “market perform” rating and issued a $417.00 price objective on shares of HCA Healthcare in a report on Monday, October 27th. Morgan Stanley set a $425.00 target price on shares of HCA Healthcare in a research report on Monday, October 27th. Raymond James Financial set a $525.00 target price on HCA Healthcare in a report on Monday, October 27th. Finally, UBS Group raised their price objective on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Stock Performance

NYSE HCA opened at $474.08 on Thursday. The firm has a market capitalization of $108.18 billion, a P/E ratio of 18.33, a PEG ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $479.43. The stock has a 50-day simple moving average of $431.29 and a two-hundred day simple moving average of $394.54.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the previous year, the company posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.